Format

Send to

Choose Destination
J Pak Med Assoc. 2013 Oct;63(10):1312-5.

Glucagon-like peptide-1 receptors agonists (GLP1 RA).

Author information

1
Department of Endocrinology, Bharti Hospital, Karnal, India. brideknl@gmail.com

Abstract

The glucagon-like peptide-1 receptors agonists (GLP1RA) are a relatively new class of drugs, used for management of type 2 diabetes. This review studies the characteristics of these drugs, focusing upon their mechanism of action, intra-class differences, and utility in clinical practice. It compares them with other incretin based therapies, the dipeptidyl peptidase-IV inhibitors, and predicts future developments in the use of these molecules, while highlighting the robust indications for the use of these drugs.

PMID:
24392570
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Pakistan Medical Association
Loading ...
Support Center